|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Thoracic Medicine (Drs. Siafakas, Tzortzaki, Bouros, and Tzanakis); the Laboratory of Virology (Mr. Sourvinos and Dr. Spandidos); and the Preventive Medicine and Nutrition Clinic (Dr. Kafatos), Medical School, University of Crete, Heraklion, Greece.
Correspondence to: Nikolaos M. Siafakas MD, PhD, FCCP, Professor of Thoracic Medicine, Medical School, University of Crete, 711 10 Heraklion, Greece; e-mail: Siafak{at}cc.uch.gr
Study objectives: Cigarette smoking is the prime cause of COPD; however, only a few smokers develop the disease. In a previous study, we demonstrated that microsatellite DNA instability (MSI) is a detectable phenomenon in sputum cells of COPD patients. Therefore, we hypothesize that this genetic alteration may indicate susceptibility to COPD.
Design: In order to investigate this hypothesis, we compared smokers who developed COPD with smokers who did not develop COPD (referred to as non-COPD smokers).
Setting: Seven highly polymorphic microsatellite markers were targeted on the DNA of sputum cells and of WBCs.
Patients and participants: We studied 60 non-COPD smokers and 59 severe COPD patients with a similar smoking history (mean ± SD) of 48 ± 25 and 54 ± 33 pack-years, respectively (p = 0.77). Non-COPD smokers were tested once; COPD smokers were tested twice, with an interval of 24 months between tests.
Results: MSI was detected in 14 COPD patients (24%) but in none of the non-COPD smokers. In 10 COPD patients, MSI was exhibited by one microsatellite marker; in the remaining 4 COPD patients, MSI was exhibited by two different alleles. The most commonly affected marker was THRA1 on chromosome 17 (43%). No significant differences were found between MSI-positive and MSI-negative COPD patients for clinical or laboratory parameters, survival, and development of lung cancer. No change in the microsatellite alleles was found between the tests performed with a 24-month interval.
Conclusions: This study demonstrated that MSI was found exclusively in the sputum cells of smokers with COPD. The results support the hypothesis that MSI could be part of the complex genetic basis of COPD, and it could be a marker of the genetic alteration caused by smoking that allows COPD to develop.
Key Words: chronic bronchitis COPD emphysema genome microsatellite markers polymerase chain reaction recombination smoking sputum tobacco smoke
This article has been cited by other articles:
![]() |
W. C. Tan and T. P. Ng COPD in Asia: Where East Meets West Chest, February 1, 2008; 133(2): 517 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kim, X. Liu, T. Kobayashi, H. Conner, T. Kohyama, F.-Q. Wen, Q. Fang, S. Abe, P. Bitterman, and S. I. Rennard Reversible Cigarette Smoke Extract-Induced DNA Damage in Human Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 483 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cavazza, M. Paci, L. De Marco, G. Leporati, G. Sartori, N. Bigiani, and G. Rossi Alveolar Adenoma of the Lung: A Clinicopathologic, Immunohistochemical, and Molecular Study of an Unusual Case International Journal of Surgical Pathology, April 1, 2004; 12(2): 155 - 159. [Abstract] [PDF] |
||||
![]() |
E. Paraskakis, G. Sourvinos, F. Passam, N. Tzanakis, E.G. Tzortzaki, M. Zervou, D. Spandidos, and N.M. Siafakas Microsatellite DNA instability and loss of heterozygosity in bronchial asthma Eur. Respir. J., December 1, 2003; 22(6): 951 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
K M Fong, Y Sekido, A F Gazdar, and J D Minna Lung cancer * 9: Molecular biology of lung cancer: clinical implications Thorax, October 1, 2003; 58(10): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Onda, D. Li, S. Suzuki, I. Nakamura, S. Takenoshita, C.-H. Brogren, S. Stampanoni, and N. Rampino Expansion of Microsatellite in the Thyroid Hormone Receptor-{alpha}1 Gene Linked to Increased Receptor Expression and Less Aggressive Thyroid Cancer Clin. Cancer Res., September 1, 2002; 8(9): 2870 - 2874. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.K. Field and J.H. Youngson The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection Eur. Respir. J., August 1, 2002; 20(2): 464 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Anto, P. Vermeire, J. Vestbo, and J. Sunyer Epidemiology of chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2001; 17(5): 982 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Liloglou, P. Maloney, G. Xinarianos, M. Hulbert, M. J. Walshaw, J. R. Gosney, L. Turnbull, and J. K. Field Cancer-specific Genomic Instability in Bronchial Lavage: A Molecular Tool for Lung Cancer Detection Cancer Res., February 1, 2001; 61(4): 1624 - 1628. [Abstract] [Full Text] |
||||
![]() |
D. A. VASSILAKIS, G. SOURVINOS, D. A. SPANDIDOS, N. M. SIAFAKAS, and D. BOUROS Frequent Genetic Alterations at the Microsatellite Level in Cytologic Sputum Samples of Patients with Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1115 - 1119. [Abstract] [Full Text] |
||||
![]() |
D. A. VASSILAKIS, G. SOURVINOS, M. MARKATOS, K. PSATHAKIS, D. A. SPANDIDOS, N. M. SIAFAKAS, and D. BOUROS Microsatellite DNA Instability and Loss of Heterozygosity in Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1729 - 1733. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |